|
000
| 01061nam 2200277zi 4500 |
|---|
| 001 | 9.941198 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240731104508 |
|---|
| 006 | m o d f |
|---|
| 007 | cr |n||||||||| |
|---|
| 008 | 240729s2019 onca o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-471/2019-1E-PDF |
|---|
| 245 | 00|aBiosimilar biologic drugs. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c[2019] |
|---|
| 300 | |a1 online resource (1 unnumbered page) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Médicaments biologiques biosimilaires. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 650 | 0|aPharmaceutical biotechnology|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tMédicaments biologiques biosimilaires.|w(CaOODSP)9.941199 |
|---|
| 856 | 40|qPDF|s190 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-471-2019-1-eng.pdf |
|---|